Consult
Log In
Menu
Consult
Log in
thr3-eyes-168518-unsplash-463127-edited.jpg
rakesh-nagarajan.jpg

Rakesh Nagarajan

Founder, President, and Chief Technical and Visionary Officer

Dr. Nagarajan is a founder and the Executive Chairman of the Board at PierianDx. He is trained as a physician-scientist with deep experience in molecular biology, molecular laboratory workflows and techniques. His multiple informatics subspecialties include bioinformatics, biospecimen informatics, clinical trials informatics, and medical informatics. He currently serves on the College of American Pathologists (CAP) Molecular Oncology Committee and the Next-Generation Sequencing (NGS) Project Team and is a molecular pathology specialty inspector for the CAP. He is also an Adjunct Associate Professor at the Washington University School of Medicine Department of Pathology & Immunology.

Dr. Nagarajan was formerly an Associate Professor at the Washington University School of Medicine (WUSM) Department of Pathology & Immunology and Genetics and directed the Alvin J. Siteman Cancer Center Bioinformatics Core and the Washington University Clinical and Translational Science Award (CTSA) Biomedical Informatics Program. From 2003-2015, Dr. Nagarajan and his group developed and supported broad biomedical informatics infrastructure to facilitate clinical and translational research and to support clinical genomic testing. With more than 50 peer-reviewed publications, his laboratory collaborated on numerous clinical and genomic projects by leading in silico analyses of diverse complex disease data sets.

PierianDx will play a part in the precision medicine revolution by  integrating omics data with what is already known in the world of biomedical research, medicine, and patient clinical data to help provide actionable insights for the precise treatment and clinical management of patients."